Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/24 18:52 | 8/28/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | 8 | M.dm | 852 | 5.88 | 0 | 145 | 23 | 763 | D | ||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 6 | S | -462 | 6.73 | 0 | -69 | 7,121 | D | ||||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 6 | M.dm | 1,131 | 3.47 | 0 | 326 | 28 | 1,500 | D | ||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 6 | S.dm | -1,131 | 3.47 | 0 | -326 | 1,500 | D | |||||||||||||||
10/28/24 17:25 | 10/24/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | M.d | 144 | 4.01 | 0 | 36 | 7 | 521 | D | ||||||||||||||
10/28/24 17:25 | 10/24/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | S.d | -144 | 4.01 | 0 | -36 | 521 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |